Indraprastha Medical Corporation Ltd - 532150 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Indraprastha Medical Corporation Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate. Indraprastha Medical Corporation Ltd - 532150 - Loss of Share Certificate / Issue of Duplicate Share Certificate
Indraprastha Medical Corporation Ltd has informed BSE regarding Loss of Share Certificate / Issue of Duplicate Share Certificate. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held on 30th January, 2019, have:- 1. Re-appointed Mr. S. Regunathan (DIN : 00286505) as Independent Director of the Company, for a period of 5 consecutive years effective from 1st April, 2019 to 31st March, 2024, subject to the approval of the shareholders of the Company; 2. Re-appointed Mr. Satnam Arora (DIN : 00010667) as Independent Director of the Company, for a period of 5 consecutive years effective from 1st April, 2019 to 31st March, 2024, subject to the approval of the shareholders of the Company; 3. Re-appointed Mr. T. S. Narayanasami (DIN : 01786981) as Independent Director of the Company, for a period of 5 consecutive years effective from 1st April, 2019 to 31st March, 2024, subject to the approval of the shareholders of the Company; and 4. Re-appointed Mr. Deepak Vaidya (DIN : 000337276) as Independent Director of the Company, for a period of 5 consecutive years effective from 1st April, 2019 to 31st March, 2024, subject to the approval of the shareholders of the Company. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2018
Enclosed please find a copy of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2018, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 03:00 pm. and ended at 04.40 pm. This is for your information and record. INDRAPRASTHA MEDICAL CORP.LTD. - 532150 - Shareholding for the Period Ended December 31, 2018
Indraprastha Medical Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click here Indraprastha Medical Corporation Ltd - 532150 - Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 015150 Name of the Signatory :- Ajay Kumar SinghalDesignation :- Company Secretary and Compliance Officer Indraprastha Medical Corporation Ltd - 532150 - Closure of Trading Window
It is hereby informed that Trading Window shall remain closed from 23rd January, 2019 to 2nd February, 2019 (both days inclusive) in connection with the Board meeting scheduled to be held on 30th January, 2019. Indraprastha Medical Corporation Ltd - 532150 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31St December, 2018
INDRAPRASTHA MEDICAL CORP.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that a meeting of the Board of Directors of the Company will be held on Wednesday, 30th January, 2019, to consider and approve, the unaudited financial results for the quarter and nine months ended 31st December, 2018. Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2018
Enclosed please find a copy of the Unaudited Financial Results for the quarter and half year ended 30th September, 2018, along with a copy of the Limited Review Report by the Auditors. The Board meeting started at 03:00 pm and ended at 5.15 p.m. This is for your information and record. Closure of Trading Window
it is hereby informed that Trading Window shall remain closed from 3rd November, 2018 to 13th November, 2018 (both days inclusive) in connection with the aforesaid Board meeting of the Company.